Cargando…

Association of TRF2 expression and myeloid-derived suppressor cells infiltration with clinical outcome of patients with cutaneous melanoma

The outcome of patients with cutaneous melanoma has been strongly modified by recent advances obtained with Immune Checkpoint Inhibitors (ICIs). However, despite this breakthrough, durable response to ICIs is limited to a subset of patients. We investigated whether the expression of TRF2, which pres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ilié, Marius, Lantéri, Elisabeth, Chamorey, Emmanuel, Thamphya, Brice, Hamila, Marame, Montaudié, Henri, Picard-Gauci, Alexandra, Gardrat, Sophie, Passeron, Thierry, Lassalle, Sandra, Long-Mira, Elodie, Cherfils-Vicini, Julien, Gilson, Eric, Hofman, Véronique, Hofman, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993190/ https://www.ncbi.nlm.nih.gov/pubmed/33796413 http://dx.doi.org/10.1080/2162402X.2021.1901446

Ejemplares similares

Comparison of Two Rapid Assays for the Detection of BRAF V600 Mutations in Metastatic Melanoma including Positive Sentinel Lymph Nodes
por: Long-Mira, Elodie, et al.
Publicado: (2022)

Multiplexed Immunohistochemistry for Molecular and Immune Profiling in Lung Cancer—Just About Ready for Prime-Time?
por: Hofman, Paul, et al.
Publicado: (2019)

Inhibiting TRF1 upstream signaling pathways to target telomeres in cancer cells
por: Cherfils‐Vicini, Julien, et al.
Publicado: (2019)

A Novel Screen for Expression Regulators of the Telomeric Protein TRF2 Identified Small Molecules That Impair TRF2 Dependent Immunosuppression and Tumor Growth
por: El Maï, Mounir, et al.
Publicado: (2021)

Deep Learning Facilitates Distinguishing Histologic Subtypes of Pulmonary Neuroendocrine Tumors on Digital Whole-Slide Images
por: Ilié, Marius, et al.
Publicado: (2022)

A Real-World Experience from a Single Center (LPCE, Nice, France) Highlights the Urgent Need to Abandon Immunohistochemistry for ROS1 Rearrangement Screening of Advanced Non-Squamous Non-Small Cell Lung Cancer
por: Hofman, Véronique, et al.
Publicado: (2023)

New Targeted Therapies and Immunotherapies for Locally Advanced Periocular Malignant Tumours: Towards a New ‘Eye-Sparing’ Paradigm?
por: Martel, Arnaud, et al.
Publicado: (2021)

Monitoring BRAF and NRAS mutations with cell-free circulating tumor DNA from metastatic melanoma patients
por: Long-Mira, Elodie, et al.
Publicado: (2018)

High expression of TRF2, SOX10, and CD10 in circulating tumor microemboli detected in metastatic melanoma patients. A potential impact for the assessment of disease aggressiveness
por: Long, Elodie, et al.
Publicado: (2016)

In-House Implementation of Tumor Mutational Burden Testing to Predict Durable Clinical Benefit in Non-Small Cell Lung Cancer and Melanoma Patients
por: Heeke, Simon, et al.
Publicado: (2019)

Any Place for Immunohistochemistry within the Predictive Biomarkers of Treatment in Lung Cancer Patients?
por: Hofman, Véronique, et al.
Publicado: (2018)

Chromogenic Multiplex Immunohistochemistry Reveals Modulation of the Immune Microenvironment Associated with Survival in Elderly Patients with Lung Adenocarcinoma
por: Ilié, Marius, et al.
Publicado: (2018)

Detection of EGFR Mutations From Plasma of NSCLC Patients Using an Automatic Cartridge-Based PCR System
por: Heeke, Simon, et al.
Publicado: (2021)

TRF1 and TRF2 binding to telomeres is modulated by nucleosomal organization
por: Galati, Alessandra, et al.
Publicado: (2015)

TRF2 positively regulates SULF2 expression increasing VEGF-A release and activity in tumor microenvironment
por: Zizza, Pasquale, et al.
Publicado: (2019)

Evaluation of Sample Pooling for SARS-CoV-2 Detection in Nasopharyngeal Swab and Saliva Samples with the Idylla SARS-CoV-2 Test
por: Hofman, Paul, et al.
Publicado: (2021)

Oral gliadin‐protected superoxide dismutase in addition to phototherapy for treating non‐segmental vitiligo: A 24‐week prospective randomized placebo‐controlled study
por: Fontas, E., et al.
Publicado: (2021)

Targeted Assessment of the EGFR Status as Reflex Testing in Treatment-Naive Non-Squamous Cell Lung Carcinoma Patients: A Single Laboratory Experience (LPCE, Nice, France)
por: Lassalle, Sandra, et al.
Publicado: (2020)

A novel pathway links telomeres to NK-cell activity: Implications for immunotherapy
por: Cherfils-Vicini, Julien, et al.
Publicado: (2014)

Baseline and early functional immune response is associated with subsequent clinical outcomes of PD-1 inhibition therapy in metastatic melanoma patients
por: Gérard, Alexandre, et al.
Publicado: (2021)

“Sentinel” Circulating Tumor Cells Allow Early Diagnosis of Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease
por: Ilie, Marius, et al.
Publicado: (2014)

Que reste t-il de la microscopie électronique pour le diagnostic anatomopathologique en 2010 ?
por: Mari, Mireille, et al.
Publicado: (2010)

The N-terminal domains of TRF1 and TRF2 regulate their ability to condense telomeric DNA
por: Poulet, Anaïs, et al.
Publicado: (2012)

Setting Up an Ultra-Fast Next-Generation Sequencing Approach as Reflex Testing at Diagnosis of Non-Squamous Non-Small Cell Lung Cancer; Experience of a Single Center (LPCE, Nice, France)
por: Ilié, Marius, et al.
Publicado: (2022)

Correction to: ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity
por: Cheli, Yann, et al.
Publicado: (2021)

ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity
por: Cheli, Yann, et al.
Publicado: (2021)

TRF2 acts as a transcriptional regulator in tumor angiogenesis
por: Maï, Mounir El, et al.
Publicado: (2015)

Setting-Up a Rapid SARS-CoV-2 Genome Assessment by Next-Generation Sequencing in an Academic Hospital Center (LPCE, Louis Pasteur Hospital, Nice, France)
por: Hofman, Paul, et al.
Publicado: (2022)

Setting up a wide panel of patient-derived tumor xenografts of non–small cell lung cancer by improving the preanalytical steps
por: Ilie, Marius, et al.
Publicado: (2015)

Perspectives and Issues in the Assessment of SMARCA4 Deficiency in the Management of Lung Cancer Patients
por: Armon, Subasri, et al.
Publicado: (2021)

Optimization of EGFR mutation detection by the fully-automated qPCR-based Idylla system on tumor tissue from patients with non-small cell lung cancer
por: Ilie, Marius, et al.
Publicado: (2017)

Oxidative damage in telomeric DNA disrupts recognition by TRF1 and TRF2
por: Opresko, Patricia L., et al.
Publicado: (2005)

Circulating Tumor Cell Detection in Lung Cancer: But to What End?
por: Hofman, Véronique, et al.
Publicado: (2019)

Nitric Oxide Synthase 2 Improves Proliferation and Glycolysis of Peripheral γδ T Cells
por: Douguet, Laetitia, et al.
Publicado: (2016)

Small but Challenging Conjunctival Melanoma: New Insights, Paradigms and Future Perspectives
por: Nahon-Estève, Sacha, et al.
Publicado: (2021)

Daily Practice Assessment of KRAS Status in NSCLC Patients: A New Challenge for the Thoracic Pathologist Is Right around the Corner
por: Bontoux, Christophe, et al.
Publicado: (2022)

TRF2 and the evolution of the bilateria
por: Duttke, Sascha H.C., et al.
Publicado: (2014)

Accurate Detection of SARS-CoV-2 by Next-Generation Sequencing in Low Viral Load Specimens
por: Ilié, Marius, et al.
Publicado: (2023)

A balanced transcription between telomerase and the telomeric DNA-binding proteins TRF1, TRF2 and Pot1 in resting, activated, HTLV-1-transformed and Tax-expressing human T lymphocytes
por: Escoffier, Emmanuelle, et al.
Publicado: (2005)

ERK1/2/MAPK pathway-dependent regulation of the telomeric factor TRF2
por: Picco, Vincent, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2bgi5vgqdmpen8h2c507ra9c08